Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy

被引：0
|
作者：
Peiró, G [1 ]
Adrover, E [1 ]
Aranda, FI [1 ]
Alenda, C [1 ]
Payá, A [1 ]
Seguí, J [1 ]
机构：
[1] Hosp Gen Univ, Alacant, Spain
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
164
引用
收藏
页码：38A / 38A
页数：1
相关论文
共 50 条
  • [21] HER2/neu antisense targeting of human breast carcinoma
    Haeri Roh
    James A Pippin
    Douglas W Green
    Craig B Boswell
    Christopher T Hirose
    Nahush Mokadam
    Jeffrey A Drebin
    Oncogene, 2000, 19 : 6138 - 6143
  • [22] FISH and HER2/neu equivocal immunohistochemistry in breast carcinoma
    Okaly, Geeta Vikram Patil
    Panwar, Dipti
    Lingappa, Kavitha Bidadli
    Kumari, Prasanna
    Anand, Abhishek
    Kumar, Prashantha
    Chikkalingaiah, Manju Hosur
    Kumar, Rekha Vijay
    INDIAN JOURNAL OF CANCER, 2019, 56 (02) : 119 - 123
  • [23] Studies on factors for pathological complete response after neoadjuvant chemotherapy in relation to HER2 status in primary breast cancer
    Arima, Nobuyuki
    Nishimura, Reiki
    Muramoto, Kazuhiro
    Inayoshi, Atsushi
    Tanigawa, Tomio
    Watanabe, Sugiko
    CANCER RESEARCH, 2024, 84 (09)
  • [24] Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast
    Usui, Yuki
    Matsunuma, Ryoichi
    Yamaguchi, Kei
    Hayami, Ryosuke
    Muramatsu, Aya
    Suzuki, Makoto
    Tsuneizumi, Michiko
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1536 - 1541
  • [25] Response to neoadjuvant chemotherapy in HER2 non-overexpressing breast cancer subtypes
    Ilie, S. M.
    Desmoulins, I.
    Hennequin, A.
    Coureche-Guillaume, K.
    Arnould, L.
    Nathalie, B.
    Bertaut, A.
    Ladoire, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Predictors of Response to Trastuzumab Containing Neoadjuvant Chemotherapy in HER2 Positive Breast Cancers
    Li, X.
    Kanbour-Shakir, A.
    Dabbs, D.
    Bhargava, R.
    LABORATORY INVESTIGATION, 2012, 92 : 49A - 50A
  • [27] Predictors of Response to Trastuzumab Containing Neoadjuvant Chemotherapy in HER2 Positive Breast Cancers
    Li, X.
    Kanbour-Shakir, A.
    Dabbs, D.
    Bhargava, R.
    MODERN PATHOLOGY, 2012, 25 : 49A - 50A
  • [28] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [29] Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer reply
    Baselga, Jose
    de Azambuja, Evandro
    Bradbury, Ian
    Gelber, Richard
    LANCET, 2012, 379 (9833): : 2238 - 2238
  • [30] CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Ustaalioglu, B. B. Oven
    Vardar, F. Aker
    Bilici, A.
    Gurleyik, G.
    Erkol, B.
    Kefeli, U.
    ANNALS OF ONCOLOGY, 2014, 25
12345